What's new

Human medicines European public assessment report (EPAR): Tremfya, guselkumab, Date of authorisation: 10/11/2017, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Tremfya, guselkumab, Date of authorisation: 10/11/2017, Revision: 10, Status: Authorised

May 8, 2025 - 11:02
 0
Human medicines European public assessment report (EPAR): Tremfya, guselkumab, Date of authorisation: 10/11/2017, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Tremfya, guselkumab, Date of authorisation: 10/11/2017, Revision: 10, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Tecentriq, atezolizuma...

Next Article

Human medicines European public assessment report (EPAR): Jentadueto, linaglipti...

Related Posts

Human medicines European public assessment report (EPAR): Retacrit, epoetin zeta, Date of authorisation: 18/12/2007, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 22, 2025  0

Reflection paper on a tailored clinical approach in biosimilar development

Reflection paper on a tailored clinical approach in bio...

May 1, 2025  0

Human medicines European public assessment report (EPAR): Levetiracetam Accord, levetiracetam, Date of authorisation: 03/10/2011, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 30, 2025  0